These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 2102029
1. [Effectiveness and tolerance of long-term uricosuric treatment]. Berg H. Z Gesamte Inn Med; 1990 Dec 01; 45(23):719-20. PubMed ID: 2102029 [Abstract] [Full Text] [Related]
2. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients. Hanvivadhanakul P, Akkasilpa S, Deesomchok U. J Med Assoc Thai; 2002 Jun 01; 85 Suppl 1():S40-7. PubMed ID: 12188443 [Abstract] [Full Text] [Related]
3. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia. Akkasilpa S, Osiri M, Deesomchok U, Avihingsanon Y. J Med Assoc Thai; 2004 Sep 01; 87(9):1087-91. PubMed ID: 15516011 [Abstract] [Full Text] [Related]
4. [Long lasting normalization of uric acid after combination therapy with 300 mg allopurinol and 60 mg benzbromarone in patients with gout and hyperuricemia]. Matzkies F. Med Klin (Munich); 1992 Sep 15; 87(9):460-2. PubMed ID: 1406482 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, van de Laar MA, Brouwers JR. Ann Rheum Dis; 2009 Jan 15; 68(1):51-6. PubMed ID: 18250112 [Abstract] [Full Text] [Related]
7. [Treatment of hyperuricaemia with a combination of allopurinol and benzbromaron (author's transl)]. Matzkies F, Berg G. Dtsch Med Wochenschr; 1976 Oct 22; 101(43):1568-70. PubMed ID: 991731 [Abstract] [Full Text] [Related]
14. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Schumacher HR, Becker MA, Wortmann RL, Macdonald PA, Hunt B, Streit J, Lademacher C, Joseph-Ridge N. Arthritis Rheum; 2008 Nov 15; 59(11):1540-8. PubMed ID: 18975369 [Abstract] [Full Text] [Related]
15. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Perez-Ruiz F, Calabozo M, Pijoan JI, Herrero-Beites AM, Ruibal A. Arthritis Rheum; 2002 Aug 15; 47(4):356-60. PubMed ID: 12209479 [Abstract] [Full Text] [Related]
16. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. Dalbeth N, Kumar S, Stamp L, Gow P. J Rheumatol; 2006 Aug 15; 33(8):1646-50. PubMed ID: 16783857 [Abstract] [Full Text] [Related]
17. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro. Inokuchi T, Tsutsumi Z, Takahashi S, Ka T, Yamamoto A, Moriwaki Y, Masuzaki H, Yamamoto T. Horm Metab Res; 2009 Apr 15; 41(4):327-32. PubMed ID: 19048458 [Abstract] [Full Text] [Related]
18. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)]. Mertz DP. MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792 [Abstract] [Full Text] [Related]